OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again - Xconomy

Fox News

OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again Xconomy It wasn't too long ago that OncoGenex had high hopes that a drug called custirsen might make a big impact on the fast-moving treatment landscape for prostate cancer. A few failed trials later, however, the Bothell, WA, company has now hired a financial ... OncoGenex seeks strategic alternatives after drug study failsReuters OncoGenex's custirsen flunks late-stage study in prostate cancer; shares slump 34% premarketSeeking Alpha OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI): Consensus Estimates in ViewPress Telegraph Engelwood Daily -FTSE News -Edmonton Journal all 9 news articles »

OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again - Xconomy
Read More